In cancer patients, MHC-II restricted CD4 T cell responses against self-antigens have been detected in the circulation and at the tumor site [49,50,51,52,53,54,55,56,57,58], and a high density of tumor-infiltrating CD4 T cells correlates with good prognosis in many cancer types [59,60]. The gene discussed is CD4; the disease is neoplasm.